相关实验视频
Updated: May 15, 2025

08:28
Experimental Metastasis Assay
Published on: August 24, 2010
20.2K
m6A在癌症转移中的调节作用
Ying Zhou1, Peng Cao2, Qing Zhu1
1Division of Abdominal Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Frontiers in cell and developmental biology
|May 13, 2025
概括
N6-甲基氨酸 (m6A) RNA修改是癌症转移的关键调节者. 本综述探讨了m6A在各种转移阶段的作用及其作为抗转移策略的治疗点的潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 癌症转移是导致死亡的主要原因,具有复杂的调节机制.
- RNA的修改,特别是N6-甲基氨酸 (m6A),正在成为癌症进展的关键参与者.
- m6A是影响RNA代谢和基因表达的流行表达体标记.
研究的目的:
- 审查m6A在癌症转移中的多方面的作用.
- 为了阐明m6A修改如何影响致病途径.
- 确定针对m6A进行抗转移治疗的治疗策略.
主要方法:
- 关于m6A和癌症转移的研究的综合文献综述.
- 对m6A参与表皮质-介质酶过渡,入侵,迁移和殖民的分析.
- 评估m6A对关键瘤性通路的调节.
主要成果:
- m6A显著影响多个癌症转移的阶段.
- m6A修改调节关键的致癌途径,驱动转移性进展.
- 向m6A为新型抗转移疗法提供了一个有希望的途径.
结论:
- m6A是癌症转移的关键调节剂,具有显著的治疗潜力.
- 进一步研究m6A的监管格局对于开发有效的抗转移策略至关重要.
- 针对m6A提供了一种新的方法来打击癌症死亡率.
相关概念视频
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Master Transcription Regulators
6.8K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.8K
MicroRNAs
2.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
2.9K
Epigenetic Regulation
30.8K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
30.8K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K

